Merit Medical Systems (NASDAQ:MMSI) Upgraded to “Strong-Buy” at Wall Street Zen

Merit Medical Systems (NASDAQ:MMSI) was upgraded by equities researchers at Wall Street Zen from a “buy” rating to a “strong-buy” rating in a research report issued on Saturday.

Other analysts also recently issued research reports about the company. Wells Fargo & Company downgraded Merit Medical Systems from an “overweight” rating to an “equal weight” rating and cut their price objective for the stock from $95.00 to $78.00 in a report on Thursday, February 26th. Weiss Ratings reissued a “hold (c)” rating on shares of Merit Medical Systems in a research report on Monday, December 29th. Canaccord Genuity Group boosted their price target on shares of Merit Medical Systems from $93.00 to $99.00 and gave the company a “buy” rating in a report on Wednesday, December 17th. Robert W. Baird set a $108.00 price target on shares of Merit Medical Systems in a research report on Tuesday, December 16th. Finally, Barrington Research raised their price objective on shares of Merit Medical Systems from $106.00 to $109.00 and gave the stock an “outperform” rating in a research note on Wednesday, February 25th. Seven investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $101.25.

Merit Medical Systems Price Performance

Shares of NASDAQ:MMSI opened at $68.73 on Friday. The company has a market capitalization of $4.08 billion, a PE ratio of 32.42, a price-to-earnings-growth ratio of 2.00 and a beta of 0.62. The company has a debt-to-equity ratio of 0.46, a quick ratio of 2.95 and a current ratio of 4.34. The stock has a fifty day moving average of $76.85 and a 200-day moving average of $82.28. Merit Medical Systems has a one year low of $66.34 and a one year high of $107.27.

Merit Medical Systems (NASDAQ:MMSI) last issued its earnings results on Tuesday, February 24th. The medical instruments supplier reported $1.04 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.96 by $0.08. Merit Medical Systems had a return on equity of 13.82% and a net margin of 8.48%.The business had revenue of $393.94 million for the quarter, compared to analysts’ expectations of $390.77 million. During the same period in the previous year, the firm posted $0.93 EPS. The company’s quarterly revenue was up 10.9% on a year-over-year basis. Merit Medical Systems has set its FY 2026 guidance at 4.010-4.150 EPS. As a group, equities analysts anticipate that Merit Medical Systems will post 3.37 EPS for the current fiscal year.

Hedge Funds Weigh In On Merit Medical Systems

Institutional investors and hedge funds have recently bought and sold shares of the business. Ameritas Investment Partners Inc. increased its holdings in shares of Merit Medical Systems by 2.2% in the 2nd quarter. Ameritas Investment Partners Inc. now owns 5,973 shares of the medical instruments supplier’s stock valued at $558,000 after purchasing an additional 131 shares during the period. Norden Group LLC boosted its holdings in shares of Merit Medical Systems by 5.7% during the third quarter. Norden Group LLC now owns 2,536 shares of the medical instruments supplier’s stock worth $211,000 after purchasing an additional 137 shares during the period. Lido Advisors LLC grew its position in Merit Medical Systems by 3.8% during the fourth quarter. Lido Advisors LLC now owns 3,836 shares of the medical instruments supplier’s stock valued at $324,000 after purchasing an additional 140 shares in the last quarter. Hilltop National Bank grew its position in Merit Medical Systems by 8.7% during the third quarter. Hilltop National Bank now owns 2,119 shares of the medical instruments supplier’s stock valued at $176,000 after purchasing an additional 169 shares in the last quarter. Finally, Sowell Financial Services LLC increased its stake in Merit Medical Systems by 4.2% in the 3rd quarter. Sowell Financial Services LLC now owns 4,355 shares of the medical instruments supplier’s stock valued at $362,000 after buying an additional 174 shares during the period. Hedge funds and other institutional investors own 99.66% of the company’s stock.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.